PMID: 3768838Dec 1, 1986Paper

Essential thrombocythemias. Clinical evolutionary and biological data

Cancer
S BellucciM Boiron

Abstract

This retrospective study reviewed 94 patients, aged 6 to 90 years, with thrombocythemia. The women/men ratio was 1.76. At onset or, less commonly, during the course of the disease, 45% of the patients presented hemorrhagic manifestations, 29% thrombotic complications, and only 14% the association of hemorrhage and thrombosis. The average platelet count was 1200 X 10(9)/1, with no difference according to sex or age. Platelet hypoaggregation was seen in practically all the cases (94%), although myelofibrosis was less frequent (54%). The frequency of hemorrhages increased when the platelet count was above 1000 X 10(9)/1 (P less than 0.01), but the occurrence of thrombosis was correlated neither with platelet count nor with thrombopathy. Survival time was lengthy: 80% of survival (standard error 6%) was observed at 100 months. Transformation to acute leukemia was observed in five patients. Because the disease course is most often prolonged, therapeutic measures must be conservative: anti-aggregating drugs in small doses, and chemotherapy beginning with nonalkylating agents.

References

Jan 5, 1978·The New England Journal of Medicine·A M Gown
Mar 1, 1979·Transfusion·A L Panlilio, R F Reiss
Jan 1, 1979·Human Genetics·P Petit, H Van den Berghe
Dec 15, 1979·British Medical Journal·F E PrestonG A Davies-Jones
Aug 1, 1977·British Journal of Haematology·A K Singh, G Wetherley-Mein
Jul 1, 1978·American Heart Journal·S HussainS N Chua
Jun 1, 1978·Annals of Internal Medicine·C Y Thomas
May 24, 1976·JAMA : the Journal of the American Medical Association·H C Hoagland, M C Perry
Sep 1, 1974·Archives of Internal Medicine·I BarrB Lown
Aug 31, 1974·British Medical Journal·F E PrestonR G Malia
Oct 1, 1973·Australian and New Zealand Journal of Medicine·R P HerrmannH J Woodliff
Jul 1, 1968·Archives of Internal Medicine·M N Silverstein
Aug 1, 1969·Archives of Internal Medicine·T H SpaetM L Goldstein
Jun 1, 1969·The Journal of Clinical Investigation·L A Harker, C A Finch
May 1, 1982·Lancet·F E Preston
Jul 1, 1984·Histopathology·J J MichielsJ Abels
Oct 1, 1983·Annals of Internal Medicine·J JabailyA V Pisciotta
Feb 18, 1982·The New England Journal of Medicine·A I Schafer
Feb 1, 1983·Scandinavian Journal of Haematology·S PartanenP Vuopio
Apr 1, 1983·American Journal of Hematology·U SingalC Bishop
Apr 1, 1981·The Journal of Clinical Investigation·A Moore, R L Nachman
Jan 1, 1982·Scandinavian Journal of Haematology·D C LinchL S Wilkinson
Mar 1, 1982·American Journal of Clinical Pathology·S A Geller, E Shapiro
May 1, 1981·Archives of Internal Medicine·C WelfordD Green
Mar 1, 1981·Transfusion·M BelloniA Girolami
Apr 1, 1980·Clinical Pediatrics·D J Sceats, D Baitlon
Mar 1, 1980·Transfusion·E G Taft
Sep 5, 1980·JAMA : the Journal of the American Medical Association·H H SalemB G Firkin
Sep 26, 1980·JAMA : the Journal of the American Medical Association·H K ShamasunderW H Knospe
Nov 28, 1959·Lancet·L GIMENO ALFOSE M LEDLIE

❮ Previous
Next ❯

Citations

Jul 1, 1995·Stem Cells·T I Mughal
May 1, 1991·Annals of Hematology·Y AsanoG Shiraishi
Mar 1, 1994·Annals of Hematology·R J SchlemperJ C Eikenboom
May 1, 1993·Annals of Hematology·H MurakamiM Sawamura
Aug 1, 1993·Annals of Hematology·P J van Genderen, J J Michiels
Nov 15, 2002·International Journal of Hematology·Tiziano Barbui
Oct 1, 1995·Critical Reviews in Oncology/hematology·R LandolfiC Patrono
Feb 18, 2004·The Journal of Laboratory and Clinical Medicine·Hui-Chi HsuChi-Kuan Ho
Jan 5, 2000·Cancer Genetics and Cytogenetics·K UozumiT Arima
Mar 1, 1997·Blood Reviews·A TefferiM N Silverstein
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A SagripantiA Carpi
May 5, 1999·Critical Reviews in Oncology/hematology·T Barbui, G Finazzi
May 15, 2001·European Journal of Haematology·C A Wright, A Tefferi
Jun 14, 2002·European Journal of Haematology·Yuko HiroseSusumu Sugai
Mar 12, 2002·British Journal of Haematology·Francesco PassamontiMario Lazzarino
Dec 19, 1998·British Journal of Haematology·M RuggeriT Barbui
Nov 13, 2001·British Journal of Haematology·T NeunteuflH Gisslinger
Jun 13, 2002·British Journal of Haematology·Claire N Harrison
Aug 10, 2000·Clinical and Laboratory Haematology·H KayaE Bozkurt
Dec 3, 1999·Journal of Internal Medicine·M L RandiA Girolami
Feb 1, 1997·Medicina clínica·S Martínez RománV Cararach
Oct 27, 1998·Journal of Pediatric Hematology/oncology·H LacknerW Schwinger
Jun 1, 1991·British Journal of Haematology·T C Pearson
Oct 1, 1991·British Journal of Haematology·H GisslingerH Ludwig
Mar 1, 1991·British Journal of Haematology·J BeardT C Pearson
Feb 1, 1993·British Journal of Haematology·K V Watson, N Key
Nov 1, 1995·British Journal of Haematology·V ThibertC Legrand
Oct 1, 1989·Acta Pathologica Japonica·K HonmaK Kimura
Jun 1, 1995·The Journal of Obstetrics and Gynaecology·Z RashidN Adeeb
Sep 1, 1996·Acta Paediatrica·P J van DijkenJ P van Wouwe
Mar 1, 1990·Journal of Veterinary Internal Medicine·A S HammerM Q Bailey
Feb 26, 1999·Leukemia & Lymphoma·I MatsumuraY Kanakura
Jan 1, 1991·Leukemia & Lymphoma·A HattoriA Shibata
Oct 21, 2003·Leukemia & Lymphoma·Francesco Passamonti, Mario Lazzarino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.